Holen Sie sich die Stockscreener-App
29.11
1.46%
-0.43
Schlusskurs vom Vortag:
$29.54
Offen:
$29.66
24-Stunden-Volumen:
618.09K
Relative Volume:
1.02
Marktkapitalisierung:
$1.45B
Einnahmen:
$534.53M
Nettoeinkommen (Verlust:
$-11.45M
KGV:
-120.72
EPS:
-0.2411
Netto-Cashflow:
$48.28M
1W Leistung:
-3.05%
1M Leistung:
-10.86%
6M Leistung:
-17.01%
1J Leistung:
-11.16%
1-Tages-Spanne:
$29.00
$30.53
1-Wochen-Bereich:
$28.41
$30.53
52-Wochen-Spanne:
$28.29
$43.18
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
29.19 | 1.47B | 534.53M | -11.45M | 48.28M | -0.2411 |
|
ISRG
Intuitive Surgical Inc
|
472.18 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
160.62 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.08 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.80 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
40.92 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-18 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-02-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates - Yahoo Finance
AtriCure at The Citizens Life Sciences Conference: Strategic Growth Outlook By Investing.com - Investing.com Canada
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Moving Averages: Does AtriCure Inc have declining or rising EPS2026 Winners & Losers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Aug Opening: Is AtriCure Inc a cyclical or defensive stockEarnings Overview Summary & Daily Stock Trend Reports - baoquankhu1.vn
AtriCure, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Energy Moves: Is AtriCure Inc stock trending bullish2025 Fundamental Recap & Community Verified Trade Alerts - baoquankhu1.vn
Quarterly Risk: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEARJuly 2025 Action & Accurate Intraday Trade Tips - baoquankhu1.vn
Merger Talk: Will AtriCure Inc stock go up in YEAR2025 Biggest Moves & Fast Gain Swing Alerts - baoquankhu1.vn
AtriCure, Inc. $ATRC Position Reduced by GW&K Investment Management LLC - MarketBeat
Aug Weekly: Why is AtriCure Inc stock going down2025 Sector Review & Safe Capital Growth Trade Ideas - baoquankhu1.vn
AtriCure (ATRC) CEO receives stock awards, uses shares to cover taxes - Stock Titan
AtriCure (ATRC) CMO granted stock awards, uses shares to cover taxes - Stock Titan
AtriCure (ATRC) CTO awarded 45,588 shares, withholds 13,127 for tax - Stock Titan
AtriCure (ATRC) CSO granted stock, transfers shares to cover taxes - Stock Titan
AtriCure (ATRC) CFO granted 63,088 shares and transfers stock for taxes - Stock Titan
AtriCure (ATRC) COO receives stock awards and surrenders shares for taxes - Stock Titan
AtriCure (ATRC) CLO receives stock awards and surrenders shares for taxes - Stock Titan
A Look At AtriCure (ATRC) Valuation After Strong 2025 Earnings And Upbeat 2026 Outlook - simplywall.st
Vanguard Group Inc. Sells 65,324 Shares of AtriCure, Inc. $ATRC - MarketBeat
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 59.63% Upside as Analysts Stay Bullish - DirectorsTalk Interviews
AtriCure (NASDAQ:ATRC) Releases FY 2026 Earnings Guidance - MarketBeat
Champlain Investment Partners LLC Sells 38,541 Shares of AtriCure, Inc. $ATRC - MarketBeat
Will AtriCure’s (ATRC) 2026 Profitability Guidance Mark a Turning Point in Its Investment Narrative? - Yahoo Finance
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts - TipRanks
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 37.3% in February - MarketBeat
Reassessing AtriCure (ATRC) After Prolonged Share Price Weakness - simplywall.st
Oversold Conditions For AtriCure (ATRC) - Nasdaq
AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 55.32% Potential Upside and Analysts’ Strong Buy Ratings - DirectorsTalk Interviews
AtriCure to Participate in the Citizens Life Sciences Conference - BioSpace
Aug Opening: Is XWELL Inc exposed to currency risksSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
Price-Driven Insight from (ATRC) for Rule-Based Strategy - Stock Traders Daily
Nasdaq Moves: Is QDEL likely to announce a buybackInflation Watch & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Will AtriCure Inc. stock go up in YEARJuly 2025 Spike Watch & Safe Capital Preservation Plans - mfd.ru
AtriCure (NASDAQ:ATRC) Upgraded at Wall Street Zen - MarketBeat
Hood River Capital Management LLC's Strategic Acquisition of Atr - GuruFocus
ETFs Investing in AtriCure, Inc. Stocks - TradingView
AtriCure (NASDAQ:ATRC) Cut to Hold at Zacks Research - MarketBeat
Decoding AtriCure Inc (ATRC): A Strategic SWOT Insight - GuruFocus
AtriCure, Inc. SEC 10-K Report - TradingView
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal - Finviz
AtriCure Earnings Call Highlights Growth Amid Headwinds - TipRanks
Demystifying AtriCure: Insights From 6 Analyst Reviews - Benzinga
ATRC: Canaccord Genuity Lowers Price Target, Maintains Buy Ratin - GuruFocus
Needham reiterates Buy on AtriCure stock, keeps $45 target - Investing.com UK
Needham reiterates Buy on AtriCure stock, keeps $45 target By Investing.com - Investing.com Nigeria
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - Finviz
UBS Adjusts AtriCure Price Target to $55 From $60, Maintains Buy Rating - marketscreener.com
UBS Maintains 'Buy' Rating on AtriCure (ATRC), Lowers Price Targ - GuruFocus
Citizens Jmp Cuts AtriCure (NASDAQ:ATRC) Price Target to $52.00 - MarketBeat
AtriCure (ATRC) Analyst Maintains Rating, Lowers Price Target to $52 | ATRC Stock News - GuruFocus
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.00%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):